If you or someone you care about has acute myocarditis, understanding heart function is crucial. A measurement known as mitral annular plane systolic excursion (MAPSE) can provide important insights. In a study involving patients with acute myocarditis, those who experienced serious cardiovascular events had significantly lower MAPSE levels compared to those who did not. This means that monitoring MAPSE could help doctors identify patients at greater risk of complications, including death. The study found that both lateral and septal MAPSE were strongly linked to these risks, with lower values indicating a higher chance of adverse outcomes. This information could be vital for healthcare providers in deciding how to manage and treat patients with acute myocarditis, ensuring that those at higher risk receive the attention they need.
Could a simple heart measurement predict serious risks in myocarditis patients?
Photo by ClinicalPulse / Unsplash
What this means for you:
MAPSE is a valuable tool for predicting serious risks in patients with acute myocarditis. More on Major Adverse Cardiovascular Events
Mendelian Randomization review links Lp(a) to inflammatory protein pathways Lp(a) may influence heart disease through inflammation pathways
medRxiv · Apr 22, 2026
Serum biomarkers stratify disease severity in acute myocarditis cohorts New Blood Test Predicts Heart Attack Risk in Inflammation
medRxiv · Apr 14, 2026
Federated meta-analysis validates HEART score performance for chest pain risk stratification in EDs Federated HEART score analysis shows consistent chest pain risk prediction across six emergency departments
· Apr 9, 2026
Polypharmacy and age predict MACE in rural Montana type 2 diabetes cohort In rural diabetes care, does taking more medications signal higher heart risk?
medRxiv · Apr 4, 2026